Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice
- 23 August 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 48 (10), 2140-2146
- https://doi.org/10.1007/s00125-005-1915-z
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- GLP-1 Receptor Agonists and DPP-4 Inhibitors in the Treatment of Type 2 DiabetesHormone and Metabolic Research, 2004
- Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide ClearanceDiabetes, 1992
- Incretin Effect Due to Increased Secretion and Decreased Clearance of Insulin in Normal HumansDiabetes, 1988
- Insulin and C-Peptide Levels After Oral and Intravenous Glucose: Contribution of Enteroinsular Axis to Insulin SecretionDiabetes, 1986
- Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.JCI Insight, 1986
- New developments in the incretin conceptDiabetologia, 1985
- The renal metabolism of insulinDiabetologia, 1984
- C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and LimitationsDiabetes, 1984
- Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous GlucoseDiabetes, 1983